Large-Scale Cell Therapy Manufacturing Using 3D Bioreactors

The recent rise of cell and gene therapies opens new treatment options for a variety of severe conditions, including rare diseases, such as certain hereditary and immune diseases, and also widespread health issues, such as cancer and cardiac diseases.

Allogeneic therapies are seen as key to unlock the full potential of regenerative medicine for large patient populations. However, medical treatments often require large numbers of living human cells.

Two case studies demonstrate how Minaris Regenerative Medicine has established efficient large-scale cell production processes using 3D bioreactors for MSCs as well as T cells. The technology can be applied to a wide variety of human cells.